Related content

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients

By Scordo M.G.   Spina E.   Romeo P.   Dahl M.-L.   Bertilsson L.   Johansson I.   Sjöqvist F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 679-683

Springer Publishing Company

Access to resources Recommend Favorite

Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia

By Kuzman Martina Rojnic   Müller Daniel J  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 843-846

Future Medicine

Access to resources Recommend Favorite

Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

By Zhang Xiang Rong   Zhang Zhi Jun   Zhu Rong Xin   Yuan Yong Gui   Jenkins Trisha A   Reynolds Gavin P  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

Antipsychotic-induced Extrapyramidal Syndromes in Psychiatric Practice: A Case-control Study

By Schillevoort I.   Herings R.   Boer A.   Leufkens H.   Hugenholtz G.   Nolen W.   Roos R.  

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite